MX9800975A - Antagonistas de receptor de endotelina. - Google Patents

Antagonistas de receptor de endotelina.

Info

Publication number
MX9800975A
MX9800975A MX9800975A MX9800975A MX9800975A MX 9800975 A MX9800975 A MX 9800975A MX 9800975 A MX9800975 A MX 9800975A MX 9800975 A MX9800975 A MX 9800975A MX 9800975 A MX9800975 A MX 9800975A
Authority
MX
Mexico
Prior art keywords
receptor antagonists
endothelin receptor
triazoles
pyrazoles
compounds
Prior art date
Application number
MX9800975A
Other languages
English (en)
Inventor
Juan Ignacio Luengo
John Duncan Elliott
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MX9800975A publication Critical patent/MX9800975A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Se describe pirroles, pirazoles y triazoles novedosos, composiciones farmacéuticas que contienen estos compuestos y su uso como antagonistas de receptores de endotelina.
MX9800975A 1995-08-02 1996-08-02 Antagonistas de receptor de endotelina. MX9800975A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US179295P 1995-08-02 1995-08-02
US1098296P 1996-02-01 1996-02-01
PCT/US1996/012581 WO1997004772A1 (en) 1995-08-02 1996-08-02 Endothelin receptor antagonists

Publications (1)

Publication Number Publication Date
MX9800975A true MX9800975A (es) 1998-04-30

Family

ID=26669471

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9800975A MX9800975A (es) 1995-08-02 1996-08-02 Antagonistas de receptor de endotelina.

Country Status (25)

Country Link
US (5) US5969151A (es)
EP (2) EP0843551B1 (es)
JP (2) JPH11511133A (es)
KR (1) KR19990036032A (es)
CN (1) CN1196680A (es)
AP (1) AP9801182A0 (es)
AT (1) ATE341324T1 (es)
AU (2) AU717172B2 (es)
BG (1) BG102229A (es)
BR (1) BR9609914A (es)
CA (2) CA2228296A1 (es)
CZ (1) CZ30498A3 (es)
DE (2) DE69636597T2 (es)
EA (1) EA000952B1 (es)
ES (2) ES2273350T3 (es)
HU (1) HU220776B1 (es)
MX (1) MX9800975A (es)
NO (1) NO980422L (es)
NZ (1) NZ315846A (es)
OA (1) OA10755A (es)
PL (1) PL184272B1 (es)
RO (1) RO115802B1 (es)
SK (1) SK282584B6 (es)
TR (1) TR199800152T1 (es)
WO (2) WO1997004772A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5021171A1 (es) * 1997-12-08 2001-03-27 Smithkline Beechman Corp Sal de monoargininilo del acido(e)-3-(1-n-butil-5-(2-(2- carboxifenil)metoxi-4-clorofenil)-1h-pirazol-4-il)-2- ((5-metoxi-2,3-dihidrobenzofuran-5-il)metil)-prop-2-enoico
DE10155076A1 (de) * 2001-11-09 2003-05-22 Merck Patent Gmbh Verwendung von Endothelin-Rezeptor-Antagonisten zur Behandlung von Tumorerkrankungen
US7087630B2 (en) * 2002-06-27 2006-08-08 Nitromed, Inc. Cyclooxygenase 2 selective inhibitors, compositions and methods of use
WO2006075955A1 (en) * 2005-01-13 2006-07-20 Astrazeneca Ab Pyrazolyl acylsulfonamide derivatives as endothelin converting enzyme inhibitors and useful in the treatment of chronic obstructive pulmonary disease
US7521435B2 (en) * 2005-02-18 2009-04-21 Pharma Diagnostics, N.V. Silicon containing compounds having selective COX-2 inhibitory activity and methods of making and using the same
US8012038B1 (en) 2008-12-11 2011-09-06 Taylor Made Golf Company, Inc. Golf club head
US10086240B1 (en) 2015-08-14 2018-10-02 Taylor Made Golf Company, Inc. Golf club head
US10626096B2 (en) 2015-11-24 2020-04-21 Sanford Burnham Prebys Medical Discovery Institute Azole derivatives as apelin receptor agonist
US10773135B1 (en) 2019-08-28 2020-09-15 Taylor Made Golf Company, Inc. Golf club head

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1937241A1 (de) * 1968-08-02 1970-02-19 Sumitomo Chemical Co 3,5-Dioxopyrazolidinderivate und Verfahren zu ihrer Herstellung
JPH01211582A (ja) * 1988-02-16 1989-08-24 Tanabe Seiyaku Co Ltd ベンゾジオキソール誘導体
EP0403158A3 (en) * 1989-06-14 1991-12-18 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
EP0563238B1 (en) * 1990-12-14 2002-05-22 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
FR2682379B1 (fr) * 1991-10-09 1994-02-11 Rhone Poulenc Agrochimie Nouveaux phenylpyrazoles fongicides.
WO1994022830A1 (en) * 1993-03-31 1994-10-13 Smithkline Beecham Corporation Chemical compounds
CN1049219C (zh) * 1993-08-18 2000-02-09 万有制药株式会社 具有内皮素拮抗活性的芳香杂环并环戊烯衍生物
IL111613A0 (en) * 1993-11-12 1995-01-24 Rhone Poulenc Rorer Ltd Substituted phenyl compounds, their preparation and pharmaceutical compositions containing them
WO1996007653A1 (en) * 1994-09-02 1996-03-14 Smithkline Beecham Corporation Endothelin receptor antagonists

Also Published As

Publication number Publication date
AP9801182A0 (en) 1998-01-31
DE69636597T2 (de) 2007-08-16
EP0843551B1 (en) 2002-02-06
PL184272B1 (pl) 2002-09-30
NO980422D0 (no) 1998-01-30
CA2228293A1 (en) 1997-02-13
RO115802B1 (ro) 2000-06-30
HUP9902817A2 (hu) 1999-12-28
BG102229A (en) 1998-09-30
AU717172B2 (en) 2000-03-16
EP0843551A4 (en) 1998-08-12
ES2273350T3 (es) 2007-05-01
SK11398A3 (en) 1998-07-08
HU220776B1 (hu) 2002-05-28
CA2228296A1 (en) 1997-02-13
DE69619116T2 (de) 2002-09-19
WO1997004773A1 (en) 1997-02-13
AU6646396A (en) 1997-02-26
KR19990036032A (ko) 1999-05-25
US20020072614A1 (en) 2002-06-13
HUP9902817A3 (en) 2001-03-28
EP0843551A1 (en) 1998-05-27
EP0841925A1 (en) 1998-05-20
US6482956B2 (en) 2002-11-19
PL324745A1 (en) 1998-06-08
JPH11511133A (ja) 1999-09-28
ATE341324T1 (de) 2006-10-15
EP0841925A4 (en) 2001-10-17
NZ315846A (en) 1999-01-28
WO1997004772A1 (en) 1997-02-13
TR199800152T1 (xx) 1998-05-21
US6096897A (en) 2000-08-01
SK282584B6 (sk) 2002-10-08
CZ30498A3 (cs) 1998-07-15
EP0841925B1 (en) 2006-10-04
US6353116B1 (en) 2002-03-05
DE69636597D1 (de) 2006-11-16
AU6764596A (en) 1997-02-26
EA199800185A1 (ru) 1998-10-29
ES2171697T3 (es) 2002-09-16
NO980422L (no) 1998-03-24
BR9609914A (pt) 1999-07-06
US5958968A (en) 1999-09-28
DE69619116D1 (de) 2002-03-21
OA10755A (en) 2002-12-13
JP2001517195A (ja) 2001-10-02
EA000952B1 (ru) 2000-08-28
US5969151A (en) 1999-10-19
CN1196680A (zh) 1998-10-21

Similar Documents

Publication Publication Date Title
HUP9801692A3 (en) Benzimidazole compounds, pharmaceutical compositions containing them and their use for producing pharmaceutical compositions
IL124674A0 (en) Piperazine derivatives pharmaceutical compositions containing the same and use thereof
MY114014A (en) Imidazole compounds, compositions and use
ZA964337B (en) Pharmaceutical compositions containing irbesartan.
HUP0002050A3 (en) Substituted imidazole compounds, process for producing them, pharmaceutical compositions containing them and their use
EE03509B2 (et) Stabiilsed ravimikompositsioonid kandegaasita aerosoolide saamiseks
HUP0100266A3 (en) 1-amino-alkylcyclohexane nmda receptor antagonists, pharmaceutical compositions containing the compounds and their preparations
IL125223A0 (en) Novel substituted imidazole compounds
HK1022624A1 (en) Novel substituted imidazole compounds.
CY2369B1 (en) Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same.
MX9805628A (es) Imidazoles novedosos substituidos con cicloalquilo.
HUP9901159A3 (en) Substituted benzylaminopiperidine derivatives and use thereof, pharmaceutical compositions containing these compounds
HUP0002842A3 (en) Substituted imidazoles, process for producing them, pharmaceutical compositions containing them, their use and their intermediates
HUP0003859A3 (en) Imidazole fused heterocyclic compounds, process for their preparation, pharmaceutical compositions containing the same and their use
HUP9600256A3 (en) Substituted diphenyl-sulfonamide endothelin antagonists, pharmaceutical compositions containing the same and their medical uses
MX9801890A (es) Nuevos compuestos antagonistas selectivos del receptor nk3 humano, procedimiento para su obtencion y composiciones farmaceuticas que los contienen.
TR200002896T2 (tr) Kalsilitik Bileşimler
BG106930A (en) Substituted phenyl-piperazine derivatives, their preparation and use
BG105761A (en) Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
DE69907926D1 (de) 1,2,4-triazol-3-thion verbindungen
AP9801182A0 (en) Endothelin receptor antagonists.
ZA983997B (en) Triazole derivatives, process for their preparation and pharmaceutical compositions containing them.
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
IL129359A0 (en) Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same
HUP9801056A3 (en) Triazolones as apolipoprotein-b synthesis inhibitors, process for producing them, their use and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees